Radiotherapy in N0 head and neck cancer patients

Area of Science:

• Oncology
• Radiation Oncology
• Head and Neck Cancer Research

Background:

• Assessing the effectiveness of elective radiotherapy for N0 (no lymph node metastasis) oropharyngeal, hypopharyngeal, and supraglottic laryngeal cancers.
• Evaluating treatment outcomes from a large patient cohort treated between 1958 and 1976.

Purpose of the Study:

• To determine the efficacy of elective radiotherapy in preventing nodal disease in clinically negative necks for specific head and neck cancers.
• To analyze the impact of neck status on patient survival and disease-free survival.

Main Methods:

• Retrospective analysis of head and neck cancer patients treated at Institut Curie.
• Review of treatment data including radiation doses (4500-5500 cGy) and patient outcomes.
• Statistical evaluation of isolated node failure rates in N0 patients.

Main Results:

• Radiation doses of 4500-5500 cGy were highly successful in preventing nodal disease, with isolated node failure rates of only 2% in oropharyngeal/pharyngolaryngeal and supraglottic cancers.
• Despite a notable incidence of false-negative cases with extra-capsular spread, elective irradiation proved effective.
• Elective neck irradiation was integrated into primary cancer management with no significant additional morbidity.

Conclusions:

• Elective radiotherapy is a successful strategy for managing the neck in N0 oropharyngeal, hypopharyngeal, and supraglottic laryngeal cancers.
• The findings support the integration of elective neck irradiation into standard treatment protocols for these cancers.
• This approach offers a favorable balance between efficacy in preventing nodal metastasis and patient morbidity.